Sodium glucose co-transporter 2 inhibitors lower blood pressure by osmotic diuresis and can be considered in diabetic patients with resistant hypertension.
Keywords: SGLT2 inhibitor; canagliflozin; diabetes; obesity; resistant hypertension.